{"success":true,"data":{"pressRelease":{"id":"42095","rtpr_id":"nPn2YH4f7a","ticker":"SEED","exchange":"NASDAQ","all_tickers":["SEED"],"title":"Origin Agritech Announces Financial Results for the First Half of Fiscal Year 2026","author":"PR Newswire","published_at":"2026-05-21T12:00:12.030Z","article_body":"Origin Agritech Announces Financial Results for the First Half of Fiscal Year 2026\n\nPR Newswire\n\nBEIJING, May 21, 2026\n\nNet Loss Narrows by 44% Year-Over-Year, Driven by 44% Reduction in Operating\nExpenses\n\nBEIJING, May 21, 2026 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED)\n(the \"Company\" or \"Origin\"), a leading Chinese agricultural technology\ncompany, today announced its unaudited financial results for the six months\nended March 31, 2026.\n\nBusiness Accomplishments and Highlights for the Six Months Ended March 31,\n2026, and to date:\n\nStrategic Partnerships and Commercialization:\n\n * In March 2026, Origin formally launched the \"Aoyun 2026\" New Variety Promotion\nProgram at its 2026 Annual Marketing Conference in Changsha, Hunan Province.\nThe integrated commercial campaign is designed to accelerate market adoption\nof Origin's latest portfolio of high-performing seed products — including\nJingke 317, Jinqiao 8, Xundan 203, and Aoyu 728 — across all of China's\nprincipal corn-producing regions. As part of the launch, CEO Weibin Yan\npersonally signed performance accountability contracts for FY2026 and FY2027\nwith the Company's subsidiary general managers. Six regional teams\nconcurrently finalized spring planting season deployment plans across China's\nkey corn-growing markets.\n * In November 2025, Origin executed a patent license agreement with Shunfeng\nBioTech, bringing the Cas-SF01 gene-editing nuclease into the Company's\nbiotechnology toolkit. The license materially strengthens Origin's position in\nnext-generation corn trait development by pairing Cas-SF01 as a\nprecision-editing instrument with the Company's proprietary Hi3 induction-line\ndelivery platform, advancing the commercialization pathway for stacked-trait\nhybrids.\n * The Company's Origin Marker Biological Breeding Service Consortium,\nestablished in October 2024 with China Golden Marker Biotechnology Co., Ltd.,\ncontinued to expand its cooperative network during the reporting period,\nadvancing the licensing and commercialization pathway for Origin's GMO\ninsect-resistant and herbicide-tolerant traits and gene-editing technologies.\n * Origin has deepened collaborations with top corn breeders across different\necological zones, conducting joint crossing using core germplasm and\nleveraging the Company's nationwide testing network. Over 10,000 new corn\ncombinations have been introduced or jointly assembled this year. A project\nled by Professors Jiansheng Li and Feng Tian of China Agricultural University\nis developing new germplasm from the Suwan population. Origin has also\nintroduced the highly competitive variety Zhengtai 889 (co-developed with\nProfessor Jihua Tang of Henan Agricultural University and Mr. Zhou Qingwei of\nHenan Sutai), which ranked first in national trials, and the CAU-bred variety\nZhongnongda 8538, which performed strongly in Northwest China.\nBiotechnology Advancements:\n\n * During the 2025 winter season in South China, the Company's breeding work\nproduced over 30,000 new corn test-cross combinations, including promising\nones utilizing breakthrough germplasm such as QD14 for the Huang-Huai-Hai\nsummer corn region. Using the Hi3 gene-editing technology, Origin has been\nimproving main varieties for different ecological zones, particularly for\nplant density requirements. Leveraging two leaf-angle reduction genes\nexclusively licensed from China Agricultural University, precision \"smart\nplant type\" improvements have been completed on main varieties, including\nYufeng 303 and T391, and the Company is accelerating the commercial conversion\nof these achievements.\n * The Company continues to advance the commercialization of its BBL2-2\ntransgenic maize program, which received a GMO safety certificate from China's\nMinistry of Agriculture in May 2024. BBL2-2 incorporates dual\ninsect-resistance genes (Cry1Ab and Cry3Bb) and a glyphosate-tolerance gene\n(Cp4-epsps), providing the stacked-trait foundation for Origin's next\ngeneration of biotechnology hybrids.\n * Origin's national R&D platform now houses more than 200,000 corn germplasm\nresources. It supports in-house AI-assisted breeding programs that operate\nacross genomic selection, image-based phenotyping, and donor-recipient pairing\nfor the gene-editing pipeline, materially shortening the Company's breeding\ncycle and trait validation timeline.\nRegulatory Approvals and Licensing:\n\n * In October 2025, the Beijing Tongzhou District Market Supervision\nAdministration approved the inclusion of GMO crop seed production within\nBeijing Origin Seed Limited's business scope, enabling the Company's principal\noperating entity to participate directly in China's expanding GMO seed sector.\n * During the reporting period, Beijing Origin Seed Limited received its formal\ncrop seed production and operation license from the Beijing Municipal Bureau\nof Agriculture and Rural Affairs. Combined with the license already held by\nthe Company's subsidiary in Hainan, Origin now holds two crop seed production\nand operation licenses in China, significantly expanding its regional\nfootprint and the geographies in which it can directly produce and\ncommercialize seed.\nCorporate Strategy and Market Expansion:\n\n * In November 2025, the Company held a research and development work conference\nthat further clarified its strategic direction focused on variety aggregation,\nvariety development, and commercialization of biotechnologies, emphasizing the\nphilosophy of \"be first or be unique,\" expanding breeding approaches,\nstrengthening collaborations with top breeders and institutions, and expanding\ntesting scales, with good progress achieved to date.\n * In October 2025, Origin re-entered the Northeast China market — one of the\ncountry's primary corn-producing regions — with a Variety Showcase and\nTechnology Seminar held in Changchun, Jilin Province. The event drew more than\n200 dealer partners and industry participants and resulted in formal regional\ncommercial commitments. The Northeast initiative is supported by the Company's\nexpanded national organization, which grew from 63 to 106 professionals during\nfiscal year 2025.\n * In March 2026, the Company appointed Dr. Jian Zhang as an independent director\nof the Board. Dr. Zhang is a globally recognized authority in crop\nbiotechnology with more than two decades of senior leadership experience at\nDuPont Pioneer, Syngenta, and BASF. Concurrently, Dr. Z. James Chen rejoined\nthe Company as Chief Financial Officer. Dr. Chen previously served as Origin's\nChief Executive Officer and Chief Financial Officer in two prior tenures,\nbringing institutional continuity and deep capital markets expertise to the\nexecutive team at a critical point in the Company's Recovery phase.\nFirst Half Fiscal Year 2026 Financial Results:\n\nRevenues for the six months ended March 31, 2026, were RMB 49.2 million\n(US$7.1 million), a decrease of 31.9% from RMB 72.3 million for the six months\nended March 31, 2025. The decrease was primarily due to the strategic\ntransition in the Company's product portfolio, as we're focusing more on sales\nof new corn seed products and reducing external seed tolling services.\n\nCost of revenues for the first half of fiscal 2026 was RMB 43.7 million\n(US$6.3 million), compared to RMB 64.2 million for the same period in 2025.\n\nGross profit for the six months ended March 31, 2026, was RMB 5.5 million\n(US$0.8 million), compared to RMB 8.1 million for the first half of fiscal\n2025. Gross margin was 11.2%, consistent with the 11.2% reported in the\nprior-year period.\n\nTotal operating expenses for the first half of fiscal 2026 were RMB 18.4\nmillion (US$2.7 million), a 43.9% decrease from RMB 32.8 million in the same\nperiod a year ago.\n\n * Selling and marketing expenses were RMB 5.1 million (US$0.7 million), compared\nto RMB 2.6 million in the prior year, reflecting increased investment in the\n\"Aoyun 2026\" commercialization program and the expanded sales force.\n * General and administrative expenses decreased by 69.8% to RMB 7.6 million\n(US$1.1 million), down from RMB 25.0 million in the first half of fiscal 2025,\ndemonstrating the success of the Company's cost-control initiatives.\n * Research and development expenses were RMB 5.7 million (US$0.8 million), an\n11.1% increase from RMB 5.2 million in the prior year, as the Company\ncontinued to invest in its proprietary breeding and biotechnology pipeline.\nOperating loss for the first half of fiscal 2026 was RMB 12.9 million (US$1.9\nmillion), a reduction of 47.8% compared to an operating loss of RMB 24.7\nmillion for the first half of fiscal 2025.\n\nNet loss attributable to Origin Agritech Limited for the six months ended\nMarch 31, 2026, was RMB 14.4 million (US$2.1 million), compared to a net loss\nof RMB 25.6 million for the same period a year ago.\n\nBasic and diluted net loss per share for the first half of fiscal 2026 was RMB\n1.21 (US$0.17), compared to a net loss per share of RMB 3.55 in the first half\nof fiscal 2025.\n\nBalance Sheet and Liquidity\n\nAs of March 31, 2026, the Company had cash and cash equivalents of RMB 13.4\nmillion (US$1.9 million), compared to RMB 15.9 million as of September 30,\n2025. Total current assets were RMB 60.8 million (US$8.8 million), and total\nassets were RMB 92.6 million (US$13.4 million).\n\nTotal current liabilities were RMB 155.6 million (US$22.5 million), and total\nliabilities were RMB 168.1 million (US$24.3 million) as of March 31, 2026.\nShort-term borrowings were RMB 9.5 million (US$1.4 million).\n\nNote: The translation of Renminbi (RMB) into U.S. dollars (US$) is based on\nthe exchange rate of RMB 6.9194 to US$1.00 as of March 31, 2026.\n\nManagement Commentary\n\nMr. Weibin Yan, Chief Executive Officer of Origin Agritech, commented, \"Our\nfirst-half results demonstrate clear progress in our strategic turnaround. We\nhave transferred our sales structure to our new product portfolio to align\nwith market development, significantly reducing our operating loss and cutting\ngeneral and administrative expenses by nearly 70%. This financial discipline\nis the direct result of the accountability structures we put in place over the\npast year. While top-line revenue reflects our proactive restructuring of\noperations — phasing out older businesses while pushing new product sales\n— our gross margins remained stable, and our cash position is solid.\"\n\n\"In the previous quarter, our new variety promotion count and sales volume\nincreased. We are now executing the second phase of our strategic plan. With\nthe launch of our 'Aoyun 2026' promotion program, we are aggressively pushing\nour next-generation seed varieties into the market. We have expanded both our\nR&D product lines and our sales force, improved our R&D network,\nre-entered the critical Northeast corn corridor, and secured the necessary\nproduction licenses. Furthermore, the recent appointments of Dr. Jian Zhang to\nour Board and the return of Dr. James Chen as CFO give us an executive team\nwith stronger technical and capital markets expertise. We are positioned to\nconvert our rebuilt infrastructure into tangible commercial results.\"\n\nConference Call & Audio Webcast\n\nOrigin will host a conference call on Friday, May 22, at 8 a.m. ET with the\ninvestment community to discuss the Company's financial results and provide a\nbusiness update. The conference call will be led by Mr. Weibin Yan, Chief\nExecutive Officer, and Dr. Z. James Chen, Chief Financial Officer, who will be\navailable to answer questions.\n\nTo access the call by phone, please call 1-800-267-6316 (United States) or\n1-203-518-9783 (International) using the conference ID: ORIGIN.\n\nTo avoid delays, we encourage participants to dial into the conference call 15\nminutes before the scheduled start time. The webcast can be accessed at the\nfollowing link:\nhttps://viavid.webcasts.com/starthere.jsp?ei=1764036&tp_key=4b33d6defb\n(https://viavid.webcasts.com/starthere.jsp?ei=1764036&tp_key=4b33d6defb) .\n\nA webcast replay will be available for two weeks.\n\nAbout Origin Agritech Limited\n\nOrigin Agritech Limited, founded in 1997 and headquartered at the Origin\nR&D Center in Songzhuang, Tongzhou, Beijing, is a leading Chinese\nagricultural technology company. In crop seed biotechnologies, Origin\nAgritech's phytase corn was the first transgenic corn to receive the\nBio-Safety Certificate from China's Ministry of Agriculture. Over the years,\nOrigin has established a robust biotechnology seed pipeline, including\nproducts with glyphosate tolerance and pest resistance (Bt) traits. For\nfurther information, please visit the Company's website at originagritech.com\n(https://originagritech.com/) . The Company also maintains an X account to\nupdate investors on Company and industry developments, available at\nhttps://x.com/origin_agritech (https://x.com/origin_agritech) .\n\nFor more information, please contact:\n\nOrigin Agritech Limited Contact:\nKate Lang (Mandarin/English)\nDirector of Investor Relations\nPhone: +86 186-1839-3368\nEmail: bing.lang@originseed.com.cn (mailto:bing.lang@originseed.com.cn)\n\nInvestor Relations Contact:\nMatthew Abenante, IRC\nPresident\nStrategic Investor Relations, LLC\nTel: 347-947-2093\nEmail: matthew@strategic-ir.com (mailto:matthew@strategic-ir.com)\n\nView original\ncontent:https://www.prnewswire.com/news-releases/origin-agritech-announces-financial-results-for-the-first-half-of-fiscal-year-2026-302778474.html\n(https://www.prnewswire.com/news-releases/origin-agritech-announces-financial-results-for-the-first-half-of-fiscal-year-2026-302778474.html)\n\nSOURCE Origin Agritech Limited\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn2YH4f7a","title":"Origin Agritech Announces Financial Results for the First Half of Fiscal Year 2026","author":"PR Newswire","ticker":"SEED","created":"2026-05-21T12:00:12.030Z","tickers":["SEED"],"exchange":"NASDAQ","article_body":"Origin Agritech Announces Financial Results for the First Half of Fiscal Year 2026\n\nPR Newswire\n\nBEIJING, May 21, 2026\n\nNet Loss Narrows by 44% Year-Over-Year, Driven by 44% Reduction in Operating\nExpenses\n\nBEIJING, May 21, 2026 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED)\n(the \"Company\" or \"Origin\"), a leading Chinese agricultural technology\ncompany, today announced its unaudited financial results for the six months\nended March 31, 2026.\n\nBusiness Accomplishments and Highlights for the Six Months Ended March 31,\n2026, and to date:\n\nStrategic Partnerships and Commercialization:\n\n * In March 2026, Origin formally launched the \"Aoyun 2026\" New Variety Promotion\nProgram at its 2026 Annual Marketing Conference in Changsha, Hunan Province.\nThe integrated commercial campaign is designed to accelerate market adoption\nof Origin's latest portfolio of high-performing seed products — including\nJingke 317, Jinqiao 8, Xundan 203, and Aoyu 728 — across all of China's\nprincipal corn-producing regions. As part of the launch, CEO Weibin Yan\npersonally signed performance accountability contracts for FY2026 and FY2027\nwith the Company's subsidiary general managers. Six regional teams\nconcurrently finalized spring planting season deployment plans across China's\nkey corn-growing markets.\n * In November 2025, Origin executed a patent license agreement with Shunfeng\nBioTech, bringing the Cas-SF01 gene-editing nuclease into the Company's\nbiotechnology toolkit. The license materially strengthens Origin's position in\nnext-generation corn trait development by pairing Cas-SF01 as a\nprecision-editing instrument with the Company's proprietary Hi3 induction-line\ndelivery platform, advancing the commercialization pathway for stacked-trait\nhybrids.\n * The Company's Origin Marker Biological Breeding Service Consortium,\nestablished in October 2024 with China Golden Marker Biotechnology Co., Ltd.,\ncontinued to expand its cooperative network during the reporting period,\nadvancing the licensing and commercialization pathway for Origin's GMO\ninsect-resistant and herbicide-tolerant traits and gene-editing technologies.\n * Origin has deepened collaborations with top corn breeders across different\necological zones, conducting joint crossing using core germplasm and\nleveraging the Company's nationwide testing network. Over 10,000 new corn\ncombinations have been introduced or jointly assembled this year. A project\nled by Professors Jiansheng Li and Feng Tian of China Agricultural University\nis developing new germplasm from the Suwan population. Origin has also\nintroduced the highly competitive variety Zhengtai 889 (co-developed with\nProfessor Jihua Tang of Henan Agricultural University and Mr. Zhou Qingwei of\nHenan Sutai), which ranked first in national trials, and the CAU-bred variety\nZhongnongda 8538, which performed strongly in Northwest China.\nBiotechnology Advancements:\n\n * During the 2025 winter season in South China, the Company's breeding work\nproduced over 30,000 new corn test-cross combinations, including promising\nones utilizing breakthrough germplasm such as QD14 for the Huang-Huai-Hai\nsummer corn region. Using the Hi3 gene-editing technology, Origin has been\nimproving main varieties for different ecological zones, particularly for\nplant density requirements. Leveraging two leaf-angle reduction genes\nexclusively licensed from China Agricultural University, precision \"smart\nplant type\" improvements have been completed on main varieties, including\nYufeng 303 and T391, and the Company is accelerating the commercial conversion\nof these achievements.\n * The Company continues to advance the commercialization of its BBL2-2\ntransgenic maize program, which received a GMO safety certificate from China's\nMinistry of Agriculture in May 2024. BBL2-2 incorporates dual\ninsect-resistance genes (Cry1Ab and Cry3Bb) and a glyphosate-tolerance gene\n(Cp4-epsps), providing the stacked-trait foundation for Origin's next\ngeneration of biotechnology hybrids.\n * Origin's national R&D platform now houses more than 200,000 corn germplasm\nresources. It supports in-house AI-assisted breeding programs that operate\nacross genomic selection, image-based phenotyping, and donor-recipient pairing\nfor the gene-editing pipeline, materially shortening the Company's breeding\ncycle and trait validation timeline.\nRegulatory Approvals and Licensing:\n\n * In October 2025, the Beijing Tongzhou District Market Supervision\nAdministration approved the inclusion of GMO crop seed production within\nBeijing Origin Seed Limited's business scope, enabling the Company's principal\noperating entity to participate directly in China's expanding GMO seed sector.\n * During the reporting period, Beijing Origin Seed Limited received its formal\ncrop seed production and operation license from the Beijing Municipal Bureau\nof Agriculture and Rural Affairs. Combined with the license already held by\nthe Company's subsidiary in Hainan, Origin now holds two crop seed production\nand operation licenses in China, significantly expanding its regional\nfootprint and the geographies in which it can directly produce and\ncommercialize seed.\nCorporate Strategy and Market Expansion:\n\n * In November 2025, the Company held a research and development work conference\nthat further clarified its strategic direction focused on variety aggregation,\nvariety development, and commercialization of biotechnologies, emphasizing the\nphilosophy of \"be first or be unique,\" expanding breeding approaches,\nstrengthening collaborations with top breeders and institutions, and expanding\ntesting scales, with good progress achieved to date.\n * In October 2025, Origin re-entered the Northeast China market — one of the\ncountry's primary corn-producing regions — with a Variety Showcase and\nTechnology Seminar held in Changchun, Jilin Province. The event drew more than\n200 dealer partners and industry participants and resulted in formal regional\ncommercial commitments. The Northeast initiative is supported by the Company's\nexpanded national organization, which grew from 63 to 106 professionals during\nfiscal year 2025.\n * In March 2026, the Company appointed Dr. Jian Zhang as an independent director\nof the Board. Dr. Zhang is a globally recognized authority in crop\nbiotechnology with more than two decades of senior leadership experience at\nDuPont Pioneer, Syngenta, and BASF. Concurrently, Dr. Z. James Chen rejoined\nthe Company as Chief Financial Officer. Dr. Chen previously served as Origin's\nChief Executive Officer and Chief Financial Officer in two prior tenures,\nbringing institutional continuity and deep capital markets expertise to the\nexecutive team at a critical point in the Company's Recovery phase.\nFirst Half Fiscal Year 2026 Financial Results:\n\nRevenues for the six months ended March 31, 2026, were RMB 49.2 million\n(US$7.1 million), a decrease of 31.9% from RMB 72.3 million for the six months\nended March 31, 2025. The decrease was primarily due to the strategic\ntransition in the Company's product portfolio, as we're focusing more on sales\nof new corn seed products and reducing external seed tolling services.\n\nCost of revenues for the first half of fiscal 2026 was RMB 43.7 million\n(US$6.3 million), compared to RMB 64.2 million for the same period in 2025.\n\nGross profit for the six months ended March 31, 2026, was RMB 5.5 million\n(US$0.8 million), compared to RMB 8.1 million for the first half of fiscal\n2025. Gross margin was 11.2%, consistent with the 11.2% reported in the\nprior-year period.\n\nTotal operating expenses for the first half of fiscal 2026 were RMB 18.4\nmillion (US$2.7 million), a 43.9% decrease from RMB 32.8 million in the same\nperiod a year ago.\n\n * Selling and marketing expenses were RMB 5.1 million (US$0.7 million), compared\nto RMB 2.6 million in the prior year, reflecting increased investment in the\n\"Aoyun 2026\" commercialization program and the expanded sales force.\n * General and administrative expenses decreased by 69.8% to RMB 7.6 million\n(US$1.1 million), down from RMB 25.0 million in the first half of fiscal 2025,\ndemonstrating the success of the Company's cost-control initiatives.\n * Research and development expenses were RMB 5.7 million (US$0.8 million), an\n11.1% increase from RMB 5.2 million in the prior year, as the Company\ncontinued to invest in its proprietary breeding and biotechnology pipeline.\nOperating loss for the first half of fiscal 2026 was RMB 12.9 million (US$1.9\nmillion), a reduction of 47.8% compared to an operating loss of RMB 24.7\nmillion for the first half of fiscal 2025.\n\nNet loss attributable to Origin Agritech Limited for the six months ended\nMarch 31, 2026, was RMB 14.4 million (US$2.1 million), compared to a net loss\nof RMB 25.6 million for the same period a year ago.\n\nBasic and diluted net loss per share for the first half of fiscal 2026 was RMB\n1.21 (US$0.17), compared to a net loss per share of RMB 3.55 in the first half\nof fiscal 2025.\n\nBalance Sheet and Liquidity\n\nAs of March 31, 2026, the Company had cash and cash equivalents of RMB 13.4\nmillion (US$1.9 million), compared to RMB 15.9 million as of September 30,\n2025. Total current assets were RMB 60.8 million (US$8.8 million), and total\nassets were RMB 92.6 million (US$13.4 million).\n\nTotal current liabilities were RMB 155.6 million (US$22.5 million), and total\nliabilities were RMB 168.1 million (US$24.3 million) as of March 31, 2026.\nShort-term borrowings were RMB 9.5 million (US$1.4 million).\n\nNote: The translation of Renminbi (RMB) into U.S. dollars (US$) is based on\nthe exchange rate of RMB 6.9194 to US$1.00 as of March 31, 2026.\n\nManagement Commentary\n\nMr. Weibin Yan, Chief Executive Officer of Origin Agritech, commented, \"Our\nfirst-half results demonstrate clear progress in our strategic turnaround. We\nhave transferred our sales structure to our new product portfolio to align\nwith market development, significantly reducing our operating loss and cutting\ngeneral and administrative expenses by nearly 70%. This financial discipline\nis the direct result of the accountability structures we put in place over the\npast year. While top-line revenue reflects our proactive restructuring of\noperations — phasing out older businesses while pushing new product sales\n— our gross margins remained stable, and our cash position is solid.\"\n\n\"In the previous quarter, our new variety promotion count and sales volume\nincreased. We are now executing the second phase of our strategic plan. With\nthe launch of our 'Aoyun 2026' promotion program, we are aggressively pushing\nour next-generation seed varieties into the market. We have expanded both our\nR&D product lines and our sales force, improved our R&D network,\nre-entered the critical Northeast corn corridor, and secured the necessary\nproduction licenses. Furthermore, the recent appointments of Dr. Jian Zhang to\nour Board and the return of Dr. James Chen as CFO give us an executive team\nwith stronger technical and capital markets expertise. We are positioned to\nconvert our rebuilt infrastructure into tangible commercial results.\"\n\nConference Call & Audio Webcast\n\nOrigin will host a conference call on Friday, May 22, at 8 a.m. ET with the\ninvestment community to discuss the Company's financial results and provide a\nbusiness update. The conference call will be led by Mr. Weibin Yan, Chief\nExecutive Officer, and Dr. Z. James Chen, Chief Financial Officer, who will be\navailable to answer questions.\n\nTo access the call by phone, please call 1-800-267-6316 (United States) or\n1-203-518-9783 (International) using the conference ID: ORIGIN.\n\nTo avoid delays, we encourage participants to dial into the conference call 15\nminutes before the scheduled start time. The webcast can be accessed at the\nfollowing link:\nhttps://viavid.webcasts.com/starthere.jsp?ei=1764036&tp_key=4b33d6defb\n(https://viavid.webcasts.com/starthere.jsp?ei=1764036&tp_key=4b33d6defb) .\n\nA webcast replay will be available for two weeks.\n\nAbout Origin Agritech Limited\n\nOrigin Agritech Limited, founded in 1997 and headquartered at the Origin\nR&D Center in Songzhuang, Tongzhou, Beijing, is a leading Chinese\nagricultural technology company. In crop seed biotechnologies, Origin\nAgritech's phytase corn was the first transgenic corn to receive the\nBio-Safety Certificate from China's Ministry of Agriculture. Over the years,\nOrigin has established a robust biotechnology seed pipeline, including\nproducts with glyphosate tolerance and pest resistance (Bt) traits. For\nfurther information, please visit the Company's website at originagritech.com\n(https://originagritech.com/) . The Company also maintains an X account to\nupdate investors on Company and industry developments, available at\nhttps://x.com/origin_agritech (https://x.com/origin_agritech) .\n\nFor more information, please contact:\n\nOrigin Agritech Limited Contact:\nKate Lang (Mandarin/English)\nDirector of Investor Relations\nPhone: +86 186-1839-3368\nEmail: bing.lang@originseed.com.cn (mailto:bing.lang@originseed.com.cn)\n\nInvestor Relations Contact:\nMatthew Abenante, IRC\nPresident\nStrategic Investor Relations, LLC\nTel: 347-947-2093\nEmail: matthew@strategic-ir.com (mailto:matthew@strategic-ir.com)\n\nView original\ncontent:https://www.prnewswire.com/news-releases/origin-agritech-announces-financial-results-for-the-first-half-of-fiscal-year-2026-302778474.html\n(https://www.prnewswire.com/news-releases/origin-agritech-announces-financial-results-for-the-first-half-of-fiscal-year-2026-302778474.html)\n\nSOURCE Origin Agritech Limited\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-05-21T12:00:12.057241177Z","server_sent_at_ms":1779364812057},"received_at":"2026-05-21T12:00:12.131Z","source_url":"https://www.prnewswire.com/news-releases/origin-agritech-announces-financial-results-for-the-first-half-of-fiscal-year-2026-302778474.html"},"analysis":{"id":"31536","press_release_id":"42095","analysis_json":{"industry":{"label":"Food Products","sector":"Consumer Staples"},"redFlags":["Revenue decline of 32% YoY indicates ongoing business contraction despite cost cuts","Total liabilities ($24.3M) significantly exceed total assets ($13.4M), indicating negative equity","Cash position ($1.9M) is low relative to liabilities, raising liquidity concerns"],"eventType":"earnings","narrative":"Origin Agritech reported H1 FY2026 revenue of $7.1 million, down 32% year-over-year, as the company phases out older tolling services to focus on new seed varieties.\n\nDespite the top-line decline, the net loss narrowed 44% to $2.1 million and the operating loss dropped 48% to $1.9 million, driven by a 70% cut in general and administrative expenses.\n\nThe company highlighted strategic progress, including new GMO production licenses for its Beijing subsidiary, a patent license with Shunfeng BioTech, and the return of Dr. Z. James Chen as CFO alongside the appointment of Dr. Jian Zhang to the board.","sentiment":"mixed","agentHooks":{"shouldPost":true,"suggestedAngle":"SEED cuts losses in half while revenue drops 32%; turnaround strategy relies on new GMO licenses and executive reshuffle."},"keyFigures":{"revenue":7100000,"revenueYoy":"-31.9%","customDimensions":{"gross_margin":"11.2%","net_loss_usd":2100000,"gross_profit_usd":800000,"total_assets_usd":13400000,"operating_loss_usd":1900000,"total_liabilities_usd":24300000,"operating_expenses_usd":2700000,"cash_and_equivalents_usd":1900000,"short_term_borrowings_usd":1400000}},"quotedText":"Our first-half results demonstrate clear progress in our strategic turnaround. We have transferred our sales structure to our new product portfolio to align with market development, significantly reducing our operating loss and cutting general and administrative expenses by nearly 70%.","namedEntities":{"people":[{"name":"Weibin Yan","role":"CEO"},{"name":"Dr. Z. James Chen","role":"CFO"},{"name":"Dr. Jian Zhang","role":"Independent Director"},{"name":"Jiansheng Li","role":"Professor, China Agricultural University"},{"name":"Feng Tian","role":"Professor, China Agricultural University"},{"name":"Jihua Tang","role":"Professor, Henan Agricultural University"},{"name":"Zhou Qingwei","role":"Henan Sutai"},{"name":"Kate Lang","role":"Director of Investor Relations"},{"name":"Matthew Abenante","role":"President, Strategic Investor Relations, LLC"}],"products":["Aoyun 2026","Jingke 317","Jinqiao 8","Xundan 203","Aoyu 728","Cas-SF01","Hi3","Zhengtai 889","Zhongnongda 8538","QD14","Yufeng 303","T391","BBL2-2","phytase corn"],"companies":[{"name":"Origin Agritech Ltd.","ticker":"SEED","relationship":"filer"},{"name":"Shunfeng BioTech","relationship":"partner"},{"name":"China Golden Marker Biotechnology Co., Ltd.","relationship":"partner"},{"name":"China Agricultural University","relationship":"research partner"},{"name":"Henan Agricultural University","relationship":"research partner"},{"name":"Henan Sutai","relationship":"partner"},{"name":"Beijing Origin Seed Limited","relationship":"subsidiary"},{"name":"DuPont Pioneer","relationship":"former employer of Dr. Jian Zhang"},{"name":"Syngenta","relationship":"former employer of Dr. Jian Zhang"},{"name":"BASF","relationship":"former employer of Dr. Jian Zhang"},{"name":"Strategic Investor Relations, LLC","relationship":"IR firm"}],"dollarAmounts":[{"amount":"US$7.1 million","context":"H1 FY2026 revenue"},{"amount":"US$6.3 million","context":"H1 FY2026 cost of revenues"},{"amount":"US$0.8 million","context":"H1 FY2026 gross profit"},{"amount":"US$2.7 million","context":"H1 FY2026 operating expenses"},{"amount":"US$1.9 million","context":"H1 FY2026 operating loss"},{"amount":"US$2.1 million","context":"H1 FY2026 net loss"},{"amount":"US$1.9 million","context":"Cash and cash equivalents as of March 31, 2026"},{"amount":"US$13.4 million","context":"Total assets as of March 31, 2026"},{"amount":"US$24.3 million","context":"Total liabilities as of March 31, 2026"},{"amount":"US$1.4 million","context":"Short-term borrowings as of March 31, 2026"}]},"materialImpact":{"score":3,"reasoning":"Revenue declined 32% YoY due to strategic restructuring, but operating loss narrowed 48% and net loss narrowed 44% due to aggressive cost-cutting. The release also announces key executive/board changes (CFO return, new independent director) and regulatory progress (GMO licenses), signaling a turnaround phase rather than pure distress."},"tickerRelevance":{"others":[],"primary":"SEED"},"globalImportance":25,"audienceRelevance":15,"eventTypeSecondary":["executive_change","board_change"],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"earnings_turnaround","sectorWeight":"low","householdBrandBoost":0,"marketCapAdjustment":"negative_equity_risk","retailFavoriteBoost":0}},"event_type":"earnings","event_type_secondary":["executive_change","board_change"],"sentiment":"mixed","material_impact_score":3,"narrative":"Origin Agritech reported H1 FY2026 revenue of $7.1 million, down 32% year-over-year, as the company phases out older tolling services to focus on new seed varieties.\n\nDespite the top-line decline, the net loss narrowed 44% to $2.1 million and the operating loss dropped 48% to $1.9 million, driven by a 70% cut in general and administrative expenses.\n\nThe company highlighted strategic progress, including new GMO production licenses for its Beijing subsidiary, a patent license with Shunfeng BioTech, and the return of Dr. Z. James Chen as CFO alongside the appointment of Dr. Jian Zhang to the board.","key_figures":{"revenue":7100000,"revenueYoy":"-31.9%","customDimensions":{"gross_margin":"11.2%","net_loss_usd":2100000,"gross_profit_usd":800000,"total_assets_usd":13400000,"operating_loss_usd":1900000,"total_liabilities_usd":24300000,"operating_expenses_usd":2700000,"cash_and_equivalents_usd":1900000,"short_term_borrowings_usd":1400000}},"named_entities":{"people":[{"name":"Weibin Yan","role":"CEO"},{"name":"Dr. Z. James Chen","role":"CFO"},{"name":"Dr. Jian Zhang","role":"Independent Director"},{"name":"Jiansheng Li","role":"Professor, China Agricultural University"},{"name":"Feng Tian","role":"Professor, China Agricultural University"},{"name":"Jihua Tang","role":"Professor, Henan Agricultural University"},{"name":"Zhou Qingwei","role":"Henan Sutai"},{"name":"Kate Lang","role":"Director of Investor Relations"},{"name":"Matthew Abenante","role":"President, Strategic Investor Relations, LLC"}],"products":["Aoyun 2026","Jingke 317","Jinqiao 8","Xundan 203","Aoyu 728","Cas-SF01","Hi3","Zhengtai 889","Zhongnongda 8538","QD14","Yufeng 303","T391","BBL2-2","phytase corn"],"companies":[{"name":"Origin Agritech Ltd.","ticker":"SEED","relationship":"filer"},{"name":"Shunfeng BioTech","relationship":"partner"},{"name":"China Golden Marker Biotechnology Co., Ltd.","relationship":"partner"},{"name":"China Agricultural University","relationship":"research partner"},{"name":"Henan Agricultural University","relationship":"research partner"},{"name":"Henan Sutai","relationship":"partner"},{"name":"Beijing Origin Seed Limited","relationship":"subsidiary"},{"name":"DuPont Pioneer","relationship":"former employer of Dr. Jian Zhang"},{"name":"Syngenta","relationship":"former employer of Dr. Jian Zhang"},{"name":"BASF","relationship":"former employer of Dr. Jian Zhang"},{"name":"Strategic Investor Relations, LLC","relationship":"IR firm"}],"dollarAmounts":[{"amount":"US$7.1 million","context":"H1 FY2026 revenue"},{"amount":"US$6.3 million","context":"H1 FY2026 cost of revenues"},{"amount":"US$0.8 million","context":"H1 FY2026 gross profit"},{"amount":"US$2.7 million","context":"H1 FY2026 operating expenses"},{"amount":"US$1.9 million","context":"H1 FY2026 operating loss"},{"amount":"US$2.1 million","context":"H1 FY2026 net loss"},{"amount":"US$1.9 million","context":"Cash and cash equivalents as of March 31, 2026"},{"amount":"US$13.4 million","context":"Total assets as of March 31, 2026"},{"amount":"US$24.3 million","context":"Total liabilities as of March 31, 2026"},{"amount":"US$1.4 million","context":"Short-term borrowings as of March 31, 2026"}]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-05-21T12:07:41.997Z","global_importance":25,"audience_relevance":15,"importance_components":{"tickerTier":"small-cap","eventGravity":"earnings_turnaround","sectorWeight":"low","householdBrandBoost":0,"marketCapAdjustment":"negative_equity_risk","retailFavoriteBoost":0}},"durationMs":40555,"modelName":"george-droid-qwen-72b"}}